Sri Lanka vs Togo: Previously treated cases tested for RR-/MDR-TB
Sri Lanka
100.0%
in 2024
Togo
100.0%
in 2024
Sri Lanka rank
1st
Togo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Sri Lanka
- Togo
How they compare
Sri Lanka currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 3 times across 16 shared years of data; in 2007 it was Sri Lanka ahead.
Sri Lanka ranks 1st and Togo ranks 1st of 180 countries.
Across the 3 decades both report, Sri Lanka averaged higher in 2 and Togo in 1.
Head to head by decade
| Decade | Sri Lanka | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 90.3% | 12.6% | 77.7% | Sri Lanka |
| 2010s | 84.1% | 61.3% | 22.8% | Sri Lanka |
| 2020s | 81.5% | 90.2% | 8.8% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Sri Lanka or Togo?
- Sri Lanka, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Sri Lanka and Togo?
- 0.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Sri Lanka and Togo?
- 16 years are reported by both, from 2007 to 2024.
- How do Sri Lanka and Togo rank globally for previously treated cases tested for rr-/mdr-tb?
- Sri Lanka ranks 1st and Togo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.